Covalon Technologies Ltd. (COV.V: Quote), a medical technologies company, announced FDA clearance of SurgiClear antimicrobial silicone adhesive film dressing designed to cover and protect wound sites and wound closure devices, as well as secure other primary dressings to a patient's skin.
Covalon said its antimicrobial silicone adhesive allows clinicians to monitor wounds through its clear waterproof film so patients can resume normal activity without fear of contamination or damage to a wound site.
"The FDA clearance of SurgiClear, the clearance of its sister product IV Clear a few months ago, and very strong clinical feedback received to date provides Covalon with all of the validity necessary to license and sell both products," said Brian Pedlar, Covalon's Chief Executive Officer.
Click here to receive FREE breaking news email alerts for Covalon Technologies Ltd and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org